XML 39 R25.htm IDEA: XBRL DOCUMENT

Cash and Marketable Securities (Tables)

6 Months Ended

Jun. 30, 2025

Cash and Cash Equivalents [Abstract]

Summary of Reconciliation of Cash and Cash Equivalents

A reconciliation of cash, cash equivalents and restricted cash reported within the condensed consolidated balance sheets to the amount reported within the condensed consolidated statements of cash flows is shown in the table below (in thousands):


	June 30, 2025		June 30, 2024
Cash and cash equivalents	$	68,212	$	95,782
Restricted cash	551		588
Total cash, cash equivalents and restricted cash at the end of the period	$	68,763	$	96,370

Summary of Marketable Securities

The amortized cost, unrealized holding gains and fair value of the Company’s marketable securities by major security type at each balance sheet date are summarized in the tables below (in thousands):


	June 30, 2025
	Amortized Cost		Unrealized Holding Gains		Unrealized Holding Loss		Fair Value
Short-term marketable securities:
U.S. agency securities	$	85,876	$	821	$	(2)	$	86,695
Corporate debt securities	32,167		365		(2)		32,530
Total short-term marketable securities	$	118,043	$	1,186	$	(4)	$	119,225


	December 31, 2024
	Amortized Cost		Unrealized Holding Gains		Unrealized Holding Loss		Fair Value
Short-term marketable securities:
U.S. agency securities	$	90,918	$	1,652	$	(4)	$	92,566
Corporate debt securities	55,046		718		—		55,764
Total short-term marketable securities	$	145,964	$	2,370	$	(4)	$	148,330